Tomoyuki Sumizawa
- Oncology top 0.5%
- Molecular Biology top 5%
- Cancer Research top 2%
- Surgery top 10%
- Pediatrics, Perinatology and Child Health top 2%
- Co-authors
- Tatsuhiko FurukawaShin‐ichi AkiyamaZhe‐Sheng ChenMisako HaraguchiShin-ichi AkiyamaTakashi AikouKazutaka MiyaderaS Akiyama
- Topics
- Drug Transport and Resistance Mechanisms (54 papers)Cancer therapeutics and mechanisms (12 papers)Cancer, Hypoxia, and Metabolism (11 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Tomoyuki Sumizawa
94 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 111
- Oncology 2.7k
- Molecular Biology 2.2k
- Cancer Research 813
- Surgery 484
- Pediatrics, Perinatology and Child Health 471
Countries citing papers authored by Tomoyuki Sumizawa
This map shows the geographic impact of Tomoyuki Sumizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Sumizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Sumizawa more than expected).
Fields of papers citing papers by Tomoyuki Sumizawa
This network shows the impact of papers produced by Tomoyuki Sumizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Sumizawa. The network helps show where Tomoyuki Sumizawa may publish in the future.
Co-authorship network of co-authors of Tomoyuki Sumizawa
This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Sumizawa. A scholar is included among the top collaborators of Tomoyuki Sumizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Sumizawa. Tomoyuki Sumizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 50 | |
| 3 | 11 | |
| 4 | 7 | |
| 5 | 30 | |
| 6 | 13 | |
| 7 | 31 | |
| 8 | 63 | |
| 9 | 機能的な肺耐性関連タンパク質(LRP)の発現により予測される成人T細胞白血病(ATL)の不良転帰 | 2 |
| 10 | 25 | |
| 11 | 15 | |
| 12 | 120 | |
| 13 | 29 | |
| 14 | 169 | |
| 15 | 22 | |
| 16 | 40 | |
| 17 | 27 | |
| 18 | 23 | |
| 19 | 29 | |
| 20 | 25 |
About Tomoyuki Sumizawa
Tomoyuki Sumizawa is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 94 papers that have together received 4.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (54 papers), Cancer therapeutics and mechanisms (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (813 citations) and Molecular Biology (2.2k citations). Tomoyuki Sumizawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tatsuhiko Furukawa, Shin‐ichi Akiyama, Zhe‐Sheng Chen, Misako Haraguchi, Shin-ichi Akiyama, Takashi Aikou, Kazutaka Miyadera, S Akiyama, Yuji Yamada and Shin‐ichi Akiyama. Their work appears in journals such as Science, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.